[The Medical Products Agency is following up Roaccutane to assure patients' safety].
Gerdén
Barbro
B
Sjölin-Forsberg
Gunilla
G
Trolin
Ingrid
I
D000152:Acne Vulgaris / Q000188:drug therapy; D003879:Dermatologic Agents / Q000009:adverse effects; D004335:Drug and Narcotic Control; D006801:Humans; D015474:Isotretinoin / Q000009:adverse effects; D012449:Safety; D013548:Sweden
D003879:Dermatologic Agents; D015474:Isotretinoin